Your browser doesn't support javascript.
loading
European patch test results with audit allergens as candidates for inclusion in the European Baseline Series, 2019/20: Joint results of the ESSCAA and the EBSB working groups of the ESCD, and the GEIDACC.
Uter, Wolfgang; Wilkinson, S Mark; Aerts, Olivier; Bauer, Andrea; Borrego, Leopoldo; Buhl, Timo; Cooper, Susan M; Dickel, Heinrich; Gallo, Rosella; Giménez-Arnau, Ana M; John, Swen M; Navarini, Alexander A; Pesonen, Maria; Pónyai, Györgyi; Rustemeyer, Thomas; Schliemann, Sibylle; Schubert, Steffen; Schuttelaar, Marie-Louise A; Valiukeviciene, Skaidra; Wagner, Nicola; Weisshaar, Elke; Gonçalo, Margarida.
Afiliação
  • Uter W; Department of Medical Informatics, Biometry and Epidemiology, Friedrich-Alexander Universität Erlangen/Nürnberg, Erlangen, Germany.
  • Wilkinson SM; Dermatology Department, Leeds Teaching Hospitals NHS Trust, Leeds, UK.
  • Aerts O; Department of Dermatology, University Hospital Antwerp (UZA) and Research group Immunology, Infla-Med Centre of Excellence, University of Antwerp, Antwerp, Belgium.
  • Bauer A; Department of Dermatology, University Allergy Centre, Medical Faculty Carl Gustav Carus, Technical University Dresden, Dresden, Germany.
  • Borrego L; Complejo Hospitalario Universitario Insular Materno Infantil. Universidad de las Palmas de Gran Canaria, Las Palmas de Gran Canaria, Spain.
  • Buhl T; Department of Dermatology, Venereology and Allergology, University Medical Center Göttingen, Göttingen, Germany.
  • Cooper SM; Department of Dermatology, Oxford University Hospitals NHS Trust, Oxford, UK.
  • Dickel H; Department of Dermatology, Venereology and Allergology, St. Josef Hospital, Ruhr University Bochum, Bochum, Germany.
  • Gallo R; Clinica Dermatologica, Department of Health Sciences, University of Genoa, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.
  • Giménez-Arnau AM; Department of Dermatology, Hospital del Mar, Universitat Autònoma de Barcelona, Barcelona, Spain.
  • John SM; Department of Dermatology and Environmental Medicine, Institute for Interdisciplinary Dermatologic Prevention and Rehabilitation (iDerm), University of Osnabrück, Osnabrück, Germany.
  • Navarini AA; Lower Saxony Institute for Occupational Dermatology (NIB), Osnabrück, Germany.
  • Pesonen M; Department of Biomedicine, University Hospital Basel, Basel, Switzerland.
  • Pónyai G; Occupational Health Unit, Finnish Institute of Occupational Health, Helsinki, Finland.
  • Rustemeyer T; Department of Dermatology, Venerology and Dermatooncology, Semmelweis University, Budapest, Hungary.
  • Schliemann S; Department of Dermatology-Allergology, Amsterdam University Medical Centers, Amsterdam, The Netherlands.
  • Schubert S; Department of Dermatology, University Hospital Jena, Jena, Germany.
  • Schuttelaar MA; Information Network of Departments of Dermatology, Institute at the University Medical Centre Göttingen, Göttingen, Germany.
  • Valiukeviciene S; Department of Dermatology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
  • Wagner N; Department of Skin and Venereal Diseases, Lithuanian University of Health Sciences, Kaunas, Lithuania.
  • Weisshaar E; Department of Dermatology, University Hospital of Erlangen, University of Erlangen-Nuremberg (FAU), Erlangen, Germany.
  • Gonçalo M; Occupational Dermatology, Department of Dermatology, University Hospital Heidelberg, Heidelberg, Germany.
Contact Dermatitis ; 86(5): 379-389, 2022 May.
Article em En | MEDLINE | ID: mdl-35099073
ABSTRACT

BACKGROUND:

In 2019, a number of allergens (haptens), henceforth, "the audit allergens," were considered as potential additions to the European Baseline Series (EBS), namely, sodium metabisulfite, 2-bromo-2-nitropropane-1,3-diol, diazolidinyl urea, imidazolidinyl urea, Compositae mix II (2.5% or 5% pet), linalool hydroperoxides (lin-OOH), limonene hydroperoxides (lim-OOH), benzisothiazolinone (BIT), octylisothiazolinone (OIT), decyl glucoside, and lauryl glucoside; Evernia furfuracea (tree moss), was additionally tested by some departments as well.

OBJECTIVES:

To collect further data on patch test reactivity and clinical relevance of the audit allergens in consecutive patients across Europe.

METHODS:

Patch test data covering the audit allergens in 2019 and 2020 were collected by those departments of the European Surveillance System on Contact Allergies testing these, as well as further collaborators from the EBS working group of the European Society of Contact Dermatitis (ESCD), and the Spanish Grupo Español de Investigación en Dermatitis de Contacto y Alergia Cutánea. As patch test outcome, reactions between day (D) 3 and D5 were considered.

RESULTS:

Altogether n = 12 403 patients were tested with any of the audit allergen. Positive reactions were most common to lin-OOH 1% pet. (8.74% [95%CI 8.14-9.37%]), followed by lin-OOH 0.5% pet., and lim-OOH 0.3% pet (5.41% [95% CI 4.95-5.89%]). Beyond these terpene hydroperoxides, BIT 0.1% pet. was the second most common allergen with 4.72% (95% CI 4.2-5.28%), followed by sodium metabisulfite 1% pet. (3.75% [95%CI 3.32-4.23%]) and Compositae mix 5% pet. (2.31% [95% CI 1.84-2.87%]). For some allergens, clinical relevance was frequently difficult to ascertain.

CONCLUSIONS:

Despite many positive patch test reactions, it remains controversial whether lin- and lim-OOH should be tested routinely, while at least the two preservatives BIT and sodium metabisulfite appear suitable. The present results are a basis for further discussion and ultimately decision on their implementation into routine testing among the ESCD members.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Alérgenos / Dermatite Alérgica de Contato Tipo de estudo: Diagnostic_studies / Etiology_studies / Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Alérgenos / Dermatite Alérgica de Contato Tipo de estudo: Diagnostic_studies / Etiology_studies / Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article